chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immunization: COVID-19 Moderna, External Administration - Pharmacy and Wellness Center  I82.403 ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 4/2/2022 BRIGHT RED BLOOD PER RECTUM I82.453 ACUTE DVT OF BILAT PERONEAL VEINS 3/21/2022 BRIGHT RED BLOOD PER RECTUM I95.89 CHRONIC HYPOTENSION 4/2/2022 BRIGHT RED BLOOD PER RECTUM I95.9 HYPOTENSION 6/17/2022 BRIGHT RED BLOOD PER RECTUM I82.403 ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 4/2/2022 UNINTENTIONAL WEIGHT LOSS I82.453 ACUTE DVT OF BILAT PERONEAL VEINS 3/21/2022 UNINTENTIONAL WEIGHT LOSS I95.89 CHRONIC HYPOTENSION 4/2/2022 UNINTENTIONAL WEIGHT LOSS I95.9 HYPOTENSION 6/17/2022 UNINTENTIONAL WEIGHT LOSS I82.403 ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 4/2/2022 RECTAL BLEEDING I82.453 ACUTE DVT OF BILAT PERONEAL VEINS 3/21/2022 RECTAL BLEEDING I95.89 CHRONIC HYPOTENSION 4/2/2022 RECTAL BLEEDING I95.9 HYPOTENSION 6/17/2022 RECTAL BLEEDING
next day after receiving the vaccine he took the bandaid off and it off skin off each end of the bandaid it was hot and had pus
This spontaneous report was received from a licensed practical nurse, referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 07-SEP-2017, the patient was vaccinated with an expired dose of ZOSTAVAX for prophylaxis, lot number: M033219, expiration date: 18-AUG-2017 (route of administration was not reported). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT). No adverse effects were reported.
Extreme arm pain. Radiates from neck down to elbow. This pain is worse than when I had 2 c-sections! Tylenol and ibuprofen do not even touch this pain.
1st injection was 06Nov2021. On 08Nov2021 and then again on 09Nov2021, had a local urticarial reaction that self resolved each time, occurred after a warm shower; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 5 year-old male patient received bnt162b2 (BNT162B2), administration date 06Nov2021 (Batch/Lot number: unknown) at the age of 5 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: URTICARIA (non-serious) with onset 08Nov2021, outcome "recovered", described as "1st injection was 06Nov2021. On 08Nov2021 and then again on 09Nov2021, had a local urticarial reaction that self resolved each time, occurred after a warm shower".   Additional information:1st injection was 06Nov2021. On 08Nov2021 and then again on 09Nov2021, had a local urticarial reaction that self resolved each time, occurred after a warm shower. No other symptoms at all, either at the time of the injection nor at each episode of local urticaria.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
08/13/2014 Mother states when she came home from work she noticed swelling on the left arm around injection site, approximately the size of a nickel. Mother gave child Benadryl @ 2pm and again at 8pm. On 08/14/2014, Mother at lunch time reported swelling had increased to greater than approximately 2 inches. Child states that it stings to touch and when bathing with soap.
CNS effects with uncontrolled seizures; This spontaneous report was received from a pharmacist via company representative and referred to a female patient of unknown age.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, lot #, expiry date, vaccination scheme, anatomical location and route of administration were not provided).  On an unknown date, the patient experienced central nervous system (CNS) effects with uncontrolled seizures. At the time of reporting, the outcome of the event was not known.   The causal relationship between the event and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.   Upon internal review, the event was determined to be medically significant.
Elbow pain, bruising, red hives, warm occurring around 1:00 PM.
Pfizer vaccine was administered outside of clinic - reported by patient   HYPOXIA 9/2/2021 UNSPECIFIED DEMENTIA, UNSPECIFIED SEVERITY, WO BEHAVIORAL DISTURBANCE
Pain and swelling around the injection site. Nausea around 8am. Red swelling in right forearm and hand around 8:30am. Body ache and headache starting around 1pm. Hives all around the body starting 8pm, and worsening/spreading drastically over next hour.
Patient daughter reported that patient was admitted to Neurology with a stroke. She has cognitive and speech impairment as well as motor impairment. She was admitted either 2-2-21 or 2-3-21. She is still in the hospital.
Information has been received from a registered nurse referring to 2 patients of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 01-OCT-2015, the patient were vaccinated with ZOSTAVAX (0.65 ml, Lot#L024997, expiration date: 06-OCT-2016), which were improperly stored for 17 days (Incorrect product storage). The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
3NOV90 Deltoid area red & edematous w/large nodule pruritus; intense itching lasting fr 1/2 day to 2 days w/some redness 1 or more nodules appear @ or near the inject site;
felt dizzy; Headache; she had chill; This is a spontaneous report from a contactable consumer (patient) received from Pfizer sponsored program. A female patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), dose 2 via an unspecified route of administration on 23Apr2021, as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 on an unspecified date. On 24Apr2021 (Saturday), the patient experienced chills. On 25Apr2021 (Sunday), she had a very light headache. On 26Apr2021 (Monday), she had a severe headache and felt dizzy. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Right upper arm had redness down to the elbow-not warm to the touch. Patient denied pain or swelling. Took Acetaminophen 500mg q4h as needed.
pt states she got lightheaded, nauseated, dry heaves, dizzy, headache, had stabbing pain in her feet.  She had sharp abdominal pains and felt like she had razor blades in her stomach.  She had fever, joint pain, muscle pain,  and chills.  She had a tightness that moved from her jaw to her chest and all of the way down the left side of her body.  On 5/6/2021 she started with diarhea, was still lightheaded and had developed a red rash on her left arm. On 5/7/2021 the rash on her arm became itchy and is starting to spread down her arm.  Pt will contact her PCP for medical advice.
vomited within a few minutes of receiving vaccines. felt warm and diaphoretic.  vomited x 1 and felt better. awoke .  Awoke next morning  -pain under arms. Looked normal. Applied a warm rag . went to school.  When he arrived home after school, noted swelling under left arm.  in our office the following day,  normal VS. Normal face and normal ROM of neck.  No cervical nodes. Distal left & right arms normal. Proximal area of right & left deltoids with mild, slightly tender induration . No erythema.   Left axilla swollen but soft. Mild tenderness. + 1 cm tender axillary node.. Full ROM of upper extremities.  No rash.
On 04/03/2000 the patient experienced chickenpox with 10 lesions. Subsequently, the patient recovered from chickenpox. Medical attention was sought. No further information is available.
This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 84-year-old female patient who received SHINGRIX (batch number B4C42, expiry date 25th April 2020). Concomitant products included Insulin. On 18th April 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In April 2018, less than a week after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb, injection site itching and injection site erythema. On 2nd May 2018, the outcome of the extensive swelling of vaccinated limb, injection site itching and injection site erythema were recovered/resolved. It was unknown if the reporter considered the extensive swelling of vaccinated limb, injection site itching and injection site erythema to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX vaccine on left deltoid. The registered pharmacist reported that the patient experienced swelling, redness, and itching at her injection site, from her shoulder to her elbow, that occurred on an unknown date and lasted for two weeks.
lt shoulder became sore @ once last wk of OCT93; It hurts to lift arm; hurts @ noc while sleeping; aching feeling; arthritis has never been this way; pain has never gone away since it first began;
This spontaneous report was received from a physician referring to a multiple unspecified patients of unknown age and gender. The patients' pertinent medical history, drug reactions, allergies and concomitant medications were not reported. On an unknown date, the patients was vaccinated with PROQUAD (strength, dose frequency, route of administration, lot# and expiration date were not reported) for prophylaxis. On an unknown date, the patients developed either a "localized reaction", a fever, an unspecified rash (unspecified location of body), and the "antibody levels were not as high". At the reporting time, the outcome of the events was unknown. The causality between the events and PROQUAD was not reported. Additional information is not expected because there was no consent to contact physician.
Adverse reaction following vaccine.  About 5 minutes after vaccination, patient flagged me from observation area, stating that he felt some sudden onset dizziness.  He asked for some water & consented to monitoring of vital signs.  Blood pressure was elevated, at 144/93; pulse 126; o2 sat 96%.  Monitoring of vitals continued at 5 minute intervals for approximately 15 more minutes. Blood pressure remained elevated.  Pulse gradually came down to 107.  O2 remained good at 98%.  Patient declined EMS call, and left once he was feeling better.
Pt received vaccine on 03/07/11, vaccine given in (R) arm, next day saw a small round erythematous which progressed over next 6 hours. Pt had fevers of 103, (+) chills, body ache & swelling in (R) upper arm more erythematous & swollen.
Patient had trouble breathing (and is Asthmatic), and turned white and almost fainted, their brother went to the care to get their inhaler, and we provided orange juice and cold water for the patient.
Information was received from a patient's son/daughter concerning their 79 year old father. The patient's concurrent conditions included  well-controlled diabetes and liver cirrhosis. On an unknown date,the patient was vaccinated with ZOSTAVAX for prophylaxis (dose, route of administration, lot number and expiration date were not reported).   On an unspecified date, the patient noted a lesion, approximately 3" in diameter on his forehead at his hairline. He denied any pain associated with the lesion. Only minor itching was present at the wounds site. After 72 hours, his doctor diagnosed a mild case of shingles (herpes zoster) and did not treat with medication. Within the following 72 hours, the itching ceased and the lesion had almost completely healed. There were no other lesions present on the patient. The causal relationship between the event and therapy with ZOSTAVAX was not reported. Additional information has been requested.
First panic attack in my life. I?ve never had anxiety or come close to a panic attack. I don?t know that it?s related to the vaccine, but I hope this information is helpful. Since that full on anxiety attack, I?ve felt sort of an onset maybe 6 or 7 separate times, but was aware of what was happening and was able to lay down and breathe my way out of it!
Unable to properly monitor his blood sugars. It is very irregular; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE FLUCTUATION (Unable to properly monitor his blood sugars. It is very irregular) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE FLUCTUATION (Unable to properly monitor his blood sugars. It is very irregular). At the time of the report, BLOOD GLUCOSE FLUCTUATION (Unable to properly monitor his blood sugars. It is very irregular) outcome was unknown.            The action taken with mRNA-1273 was Not Applicable.  Concomitant product use was not provided.  Treatment information was not provided
Rash left arm, nerve pain left side of the body, left eye twitching, headache (temple area), severe chills repeated for 6hrs, fever 12 hrs 102
Patient completed Pfizer COVID vaccine series on 6/14/2021 and 7/5/2021 from different vendor.  Patient received 3rd dose of Pfizer at our event as listed on this report.  No patient issues reported on site.
Chills, body aches, low grade fever, headache, skin sensitivity, fatigue. Symptoms still present 32 hours after vaccination.
no adverse event; physician with her practice ordered a V ARlV AX vaccine for a 9 month old, and it was administered; This spontaneous report was received from a nurse and refers to a 9 month old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On 18-MAY-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot # T029535, expiration date 01-SEP-2022, 0.5 milliliter (route and vaccination site were not provided), for prophylaxis.       .
Severe right shoulder pain. Still unable to raise arm fully.  Unable to raise arm above 45 degree angle.
visible rash to anterior chest and left side of the neck ( close to left ear). Client c/o of itching. Allegra 60 po given with water per protocol.
Information has been received from a pharmacist concerning a 9 year old male with no pertinent medical history or drug allergies, who on 23-AUG-2007 was vaccinated with a 0.5 ml SC dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. On that same day the patient developed a fever of 101.5 F a short time after the vaccination. Medical attention was sought through an ER visit. The patient was treated with OTC acetaminophen (TYLENOL) and had not responded. The patient was not recovered. There was no product quality complaint. Additional information has been requested.
lt upper arm-3 1/2 x 4" erythema urticaria like lesion, sl tender & warm to palpate;
I got the vaccine at 10:30 am and began to notice side effects at 7:30. My symptoms are fever, malaise, and migraine.
Patient came in for a visit on 01/31/2020 with a redness and swelling to injection area which was also warm to the touch.  Patient only had a local reaction and at time of the visit she notified Dr. she felt the reaction was getting better.
Pt had inconsolable crying X 5 hours, like she was in pain. No sign of swelling or redness at site.
Immediate pain from elbow to shoulder.  Pain continued for weeks. Could not raise arm due to frozen shoulder.  Saw family doctor and was referred to physical therapy for  frozen shoulder beginning ~ November 15. On December 30, there is still a "knot" deep in muscle at site of injection along with soreness.  With physical therapy, have regained significant range of motion of arm, but still sore and still working on strengthening and increasing range of motion.
tingling in the arm at site of injection; face felt hot and flushed; heart started racing; throat seemed to swell which made it hard to swallow; throat seemed to swell which made it hard to swallow; This is a Spontaneous report from a contactable consumer (patient, self-reported). A 64-year-old female patient (non pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and Expiration dates were not reported), via unspecified route of administration in left arm on 13Mar2021 at 10:30AM (at the age of 64-year-old), as single dose for COVID-19 immunization. The patient had medical history of migraine, psoriasis, high blood pressure and allergies to penicillin, sulfa and codone medications. The concomitant medication included Nortriptyline, Bupropion, Propranolol and Vitamin D2. It reported that, on 13Mar2021 at 11:30 AM, within first hour of receiving dose, the patient experienced tingling in the arm at site of injection, face felt hot and flushed, heart started racing and throat seemed to swell which made it hard to swallow and symptoms lessened after 15 minutes. The patient did not receive any treatment for the adverse event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the event was recovered on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous case reported by an other healthcare professional, describes the occurrence of administered expired product (a vaccine given two days after the expiration date) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19  immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient administered expired product (a vaccine given two days after the expiration date). At the time of the report, administered expired product (a vaccine given two days after the expiration date) resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information.
I experienced sudden onset of tinnitus in my left ear on December 13 (2 months after the booster). The tinnitus is relentless and has not subsided. I have seen an ENT doctor and audiologist. I understand that there is a possible link to tinnitus and the vaccine.
Shortness of breath, Extreme pain like arthritis all over body, migraine like  headache, pain all over muscles and skin like fibromyalgia, sick to stomach, no appetite, fever of 102 for several hours that could not go down with Tylenol every four hours, drank plenty of fluids, rested, and took hot showers. Headache subsided after two days. Arthritis and muscle aches still here as of today. Not puking anymore but still no appetite.  Honestly, this was worse than what experienced while surviving Covid two times.
high pitch unusual cry & scream for 15 mins, evening of 14JUN94;
No adverse event; they got one in Sep2022 when it came out and a second Feb2023/potential AE: patient received second Bivalent dose before authorized; This spontaneous case was reported by a patient and describes the occurrence of EXTRA DOSE ADMINISTERED (they got one in Sep2022 when it came out and a second Feb2023/potential AE: patient received second Bivalent dose before authorized) and NO ADVERSE EVENT (No adverse event) in an elderly female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.   In September 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In February 2023, received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. In February 2023, the patient experienced EXTRA DOSE ADMINISTERED (they got one in Sep2022 when it came out and a second Feb2023/potential AE: patient received second Bivalent dose before authorized). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (they got one in Sep2022 when it came out and a second Feb2023/potential AE: patient received second Bivalent dose before authorized) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (they got one in Sep2022 when it came out and a second Feb2023/potential AE: patient received second Bivalent dose before authorized).    Patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine was unknown. Concomitant medication details not reported by the reporter. It was reported that patient got one in Sep2022 when it came out and a second Feb2023. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Patient complained of dizziness, felt like she was going to faint. I checked her blood pressure and monitored her symptoms, and called the ambulance. The ambulance checked her vitals, and monitored her for approximately 10 minutes until her and the parent felt comfortable leaving.
Palpitations began at 9 pm after vaccination, i.e. approximately 9 hours later. About 1 am, severe nausea onset. Got up to go to the bathroom to vomit. After dry heaves, sat on toilet lid. Called out to husband was going to faint. Lost consciousness and fell. Returned to consciousness in less than 1 minute on the floor, some confusion lasting about 1 minute. Returned to bed with chills and sweating lasting into the next day until about 2 pm. Vomited at 9 am that same day. Dizziness persisting from onset the first evening until present time, 6/16 (4 days post-vaccination), worse when recumbent. Fatigue and headache also persistant from first night post vaccination to current. Loss of appetite, malaise from 1 day post vaccination to current.
The patient's received the injection at 10:00. After 20 minutes the patient experienced bilateral arm hives with redness and pruritus from the site of injection down to the forearm region, the skin was cool to the touch.  Appromextily 11:15, the redness and pruritus have improved. The patient declined any medication to relieve the hive. The patient was recommended to take anti-histamine and a cold pad to relieve the reaction and follow up with her primary care physician. She stayed under observation till 11:20.